Sinovac BiotechSVA
13F holders, Q2 2024 (June 30)26holders
2new positions
2sold out
1famous investor
$25.63avg. 13F price*
At the end of Q2 2024, 26 institutions reported holding Sinovac Biotech Ltd. (SVA) in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were Orbimed Advisors LLC ($340.0M), Vivo Capital, LLC ($76.3M) and Neumann Advisory Hong Kong Ltd ($2.0M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Sinovac Biotech Ltd.
- CUSIP
- P8696W104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $0 |
| Exits | 2 | $1.1M |
All 13F filers, Q1 2024 → Q2 2024: 6,232 shares bought and 164,925 shares sold, net −158,693 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Orbimed Advisors LLC | 6.76% | No change | 2,718,735 | $340.0M |
| Vivo Capital, LLC | 7.05% | No change | 11,800,000 | $76.3M |
| Neumann Advisory Hong Kong Ltd | 0.97% | No change | 315,586 | $2.0M |
| Renaissance Technologies | 0.00% | No change | 1,312,520 | $849K |
| Susquehanna International Group, LLP | 0.00% | No change | 16,430 | $106K |
| Geode Capital Management, LLC | 0.00% | No change | 27,717 | $90K |
| Wells Fargo & Company | 0.00% | Reduce -2.4% | 12,450 | $81K |
| Morgan Stanley | 0.00% | Add +13.0% | 7,824 | $51K |
| UBS Group AG | 0.00% | Reduce -25.7% | 1,557 | $10K |
| Group One Trading LLC | 0.00% | No change | 412 | $3K |
| Transamerica Financial Advisors, LLC | 0.00% | No change | 2 | $1K |
| Horizon Investments, LLC | 0.00% | No change | 52 | $336 |
| US Bancorp \de | 0.00% | New | 127 | $0 |
| Bank of America Corp. | 0.00% | Add +950.6% | 5,526 | $0 |
| Clearstead Advisors, LLC | 0.00% | No change | 500 | $0 |
| Navellier & Associates Inc. | 0.00% | Reduce -0.8% | 14,167 | $0 |
| California Public Employees Retirement System | 0.00% | No change | 68,732 | $0 |
| Royal Bank of Canada | 0.00% | Reduce -17.1% | 442 | $0 |
| Assetmark, Inc. | 0.00% | Add +23.1% | 16 | $0 |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 424 | $0 |
| Skandinaviska Enskilda Banken AB (publ) | 0.00% | No change | 40,000 | $0 |
| Spark Investment Management LLC | 0.00% | No change | 29,100 | $0 |
| Osaic Holdings, Inc. | 0.00% | New | 201 | $0 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 4 | $0 |
| Financial Gravity Asset Management, Inc. | 0.00% | Add +1.7% | 61 | $0 |
| Atlantic Edge Private Wealth Management, LLC | 0.00% | No change | 1,000 | $0 |
"% of holder's portfolio" is SVA's weight in each manager's 13F, not the share of Sinovac Biotech Ltd. the manager owns.